Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Cardio-oncology

March 14, 2018 — After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker ...

Home March 14, 2018
Home
News | Cardio-oncology

March 14, 2018 — Breast cancer patients who started taking one of two well-known heart medications at the same time they ...

Home March 14, 2018
Home
News | ACC

March 13, 2018 –  Among patients with persistently high cholesterol despite high-intensity statin therapy, the ...

Home March 13, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

February 19, 2018 — A late-breaking analysis of the landmark COMPASS study was presented at the 2018 International ...

Home February 19, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

February 13, 2018 — Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual ...

Home February 13, 2018
Home
News | Pharmaceuticals

February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the National ...

Home February 01, 2018
Home
Technology | Antiplatelet and Anticoagulation Therapies

January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of ...

Home January 22, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

January 19, 2018 — The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is ...

Home January 19, 2018
Home
News | Cardiovascular Business

January 16, 2018 — American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving ...

Home January 16, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

December 12, 2017 — Mayo Clinic researchers have shown a link between which type of oral anticoagulant a patient takes ...

Home December 12, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes associated ...

Home November 16, 2017
Home
News | Heart Failure

November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co ...

Home November 13, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 —  The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 3, 2017 — A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...

Home November 03, 2017
Home
Subscribe Now